LEADER 05886nam  22007814a 450 
001 9910455584203321
005 20200520144314.0
010   $a600-00-0402-8
010   $a1-280-50559-1
010   $a9786610505593
010   $a1-60129-419-0
035   $a(CKB)111087027617420
035   $a(EBL)267489
035   $a(OCoLC)171570238
035   $a(SSID)ssj0000139887
035   $a(PQKBManifestationID)11136621
035   $a(PQKBTitleCode)TC0000139887
035   $a(PQKBWorkID)10028642
035   $a(PQKB)11304639
035   $a(MiAaPQ)EBC267489
035   $a(Au-PeEL)EBL267489
035   $a(CaPaEBR)ebr10116487
035   $a(CaONFJC)MIL50559
035   $a(OCoLC)936834565
035   $a(EXLCZ)99111087027617420
100   $a20020712d2002      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aDisease markers in exhaled breath$b[electronic resource] $ebasic mechanisms and clinical applications /$fedited by Nandor Marczin and Magdi H. Yacoub
210   $aAmsterdam ;$aWashington, DC $cIOS Press$dc2002
215   $a1 online resource (443 p.)
225 1 $aNATO science series. Series I, Life and behavioural sciences,$x1566-7693 ;$vv. 346
300   $aAlso published in 2003 in the Lung biology in health and disease series by M. Dekker.
311   $a1-58603-273-9 
311   $a0-585-45862-6 
320   $aIncludes bibliographical references and index.
327   $a""Cover""; ""Title page""; ""Preface""; ""Sponsors""; ""List of Participants""; ""Contents""; ""Part I. Introduction to Disease Markers in Exhaled Breath""; ""Section 1. Nitric Oxide""; ""Regulation of Nitric Oxide Synthases in the Lung""; ""Nitric Oxide Production in the Lung and its Regulation by Oxygen""; ""S-Nitrosothiols in Respiratory Biology""; ""Inhibitors of Nitric Oxide Synthase: Experimental Findings and Clinical Implications""; ""Inhaled NO as a Replacement Therapy""; ""Physiology of Exhaled Nitric Oxide""; ""The ""Vascular"" Origins of Exhaled Nitric Oxide""
327   $a""Exhaled NO originates in Airway Epithelium""""NO is Generated via NOS Enzymes""; ""Technical Aspects of Exhaled NO: Investigator Point of View""; ""Technical Aspects of Exhaled Nitric Oxide: Aerocrine Point of View""; ""Section 2. Carbon Monoxide""; ""Cytoprotection by Heme Oxygenase / CO in the Lung""; ""Role of Heme Oxygenase in Airway Smooth Muscle Contractility""; ""Exhaled Carbon Monoxide is Produced in the Lungs""; ""Exhaled Carbon Monoxide is Delivered from Systemic Sources""; ""Kinetics of Carbon Monoxide Accumulation in Exhaled Breath""
327   $a""ETCOc: An Indicator of Hemolysis in Neonatal Hyperbilirubinemia""""Section 3. Volatile Organic Compounds (VOCs)""; ""Volatile Organic Compounds as Exposure Markers""; ""Volatile Organic Compounds as Markers in Normal and Diseased States""; ""Section 4. The ""Living State""""; ""The Living State: Intimate Insights through Personal Discoveries""; ""Part II. Asthma""; ""Biology of Asthma""; ""Transcriptional Regulation of Airway Inflammation""; ""Molecular Mechanisms of Steroid Actions""; ""Nitric Oxide Reactions in the Asthmatic Airway""
327   $a""Regulation of pH in the Human Airway: Mechanisms and Monitoring""""Markers in Exhaled Air and Condensate to Monitor Treatment in Asthma""; ""Extended NO Analysis Applied to Patients with Known Altered Values of Exhaled NO""; ""Exhaled Nitric Oxide and Atopy""; ""Bradykinin and Exhaled Nitric Oxide in Asthma""; ""Exhaled NO is an Optimal Marker of Severity and Responsiveness to Therapy in Asthma""; ""Superoxide-NO Interactions in Paranasal Sinus Inflammatory Diseases""; ""Part III. Chronic Lung Diseases""; ""Biology, Diagnosis and Management of COPD""
327   $a""Disease Markers in COPD: Exhaled Breath vs. Exhaled Condensate""""The Biology of Cystic Fibrosis""; ""Exhaled Markers in Cystic Fibrosis""; ""Lung Cancer Screening by Breath Analysis""; ""Nitric Oxide and Rheumatic Diseases""; ""Nitric Oxide in Hepatopulmonary Syndrome""; ""Pathological Changes in the Airways Epithelium of Liquidators of the Chernobyl Catastrophe""; ""Part IV. Transplantation""; ""Heme Oxygenase-1 and/or Carbon Monoxide can Promote Organ Graft Survival""; ""Mechanisms of and Clinical Efforts to Minimise Perioperative Lung Injury""
327   $a""Condensate Inflammatory Markers in Lung Transplantation""
330   $aThis monograph contains the contributions of invited speakers and participants at the NATO Advanced Study Institute on Disease Markers in Exhaled Breath: Basic Mechanisms and Clinical Applications, held in Greece in 2001. This ASI was designed to summarize and disseminate expert knowledge regarding this rapidly evolving field of lung biology. Breath testing dates from the earliest history of medicine and puzzled brilliant scientific minds including Linus Pauling. The recent developments hold enormous promise that analysis of exhaled breath could open a valuable new window onto human metabolism
410  0$aNATO science series.$nSeries I,$pLife and behavioural sciences ;$vv. 346.
606   $aLungs$xDiseases$xDiagnosis
606   $aBreath tests
606   $aBiochemical markers
606   $aNitric oxide$xPathophysiology
606   $aCarbon monoxide$xPathophysiology
608   $aElectronic books.
615  0$aLungs$xDiseases$xDiagnosis.
615  0$aBreath tests.
615  0$aBiochemical markers.
615  0$aNitric oxide$xPathophysiology.
615  0$aCarbon monoxide$xPathophysiology.
676   $a616.2/4075
701   $aMarczin$b Na?ndor$f1962-$0895379
701   $aYacoub$b Magdi$0895380
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910455584203321
996   $aDisease markers in exhaled breath$92000306
997   $aUNINA